Its just not fully resolved yet
doi: 10.1515/CCLM.2011.059, PMID: [DOI] [PubMed] [Google Scholar] 25.Li JM, Li LY, Qin X, Ning LJ, Lu DL, Li DL, et al
Our team is ready to assist you in scheduling an online wellness consultation and discussing the potential benefits of our services
If you have PCOS and are struggling with weight or insulin resistance, a GLP-1 may be worth discussing with your provider
Here is a summary of the data for Utah : Share of all patients who take a GLP-1: 0.7% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.4% Share of female patients with an obesity diagnosis who take a GLP-1: 5.1% Share of GLP-1 users that are female: 60.4% For reference, here are the statistics for the entire United States: Share of all patients who take a GLP-1: 1.0% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.2% Share of female patients with an obesity diagnosis who take a GLP-1: 5.2% Share of GLP-1 users that are female: 64.7% For more information, a detailed methodology, and complete results, see U.S